Northern Biologics' Series A - II Round

Northern Biologics raised a round of funding on December 19, 2016. Investors include Versant Ventures.

Northern Biologics is developing novel therapeutic antibodies for the treatment of human diseases in oncology and fibrosis.…

Articles about Northern Biologics' Series A - II Round: